Metformin does not improve survival in unselected patients with metastatic hormone-sensitive prostate cancer (mHSPC), but the drug may improve survival and other outcomes in those with high-volume ...

Both Headspace and Silvercloud – mobile apps for mental health – are associated with significant improvements in depression and anxiety.

Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.

Trial follow-up data showed no improvement in kidney failure and death risks among blood pressure-lowering strategies for patients with ADPKD.

A new CISA portal includes the ability to save and update reports and share submitted reports with colleagues or clients for third-party reporting.

Reduced risk for Alzheimer disease, vascular dementia, and Parkinson disease seen with SGLT2i use in type 2 diabetes. (HealthDay News) — For patients with type 2 diabetes, sodium-glucose cotransporter ...

Darolutamide plus androgen deprivation therapy (ADT), without docetaxel, significantly prolonged radiographic progression-free survival compared with placebo plus ADT in patients with metastatic ...

In patients with kidney cancer undergoing surgery, the risk for kidney failure (ESRD) appears no lower with partial kidney removal (nephrectomy).

70.8% of those who were aware of their hypertension status and met criteria for meds had uncontrolled hypertension ...

Weight reduction at 1 year linked to medication active agent, dosage, treatment indication, persistence of coverage ...

(HealthDay News) — The overall second primary malignancy (SPM) point estimate was 5.8% for patients receiving chimeric antigen receptor (CAR) T-cell therapy, according to a study published online in ...

In a UK Biobank study, CMM risk increased with the number of chronic pain sites, and having more pain sites increased risk of T2D, IHD, and stroke.